Intrauterine Devices

A copper intrauterine device, or IUD, with a novel design was safe, effective and well-tolerated in women during the first year of use, according to results from a phase 3 clinical trial.

Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with stage I endometrial adenocarcinoma or endometrial hyperplasia with atypia, according to results of a randomized, phase 2 study.

Levonorgestrel intrauterine devices were noninferior to copper IUDs as emergency contraception, according to research published in the New England Journal of Medicine.

Intrauterine devices effectively manage menstrual pain and bleeding in adolescents with disabilities, according to research published in Pediatrics.

About 14,000 women each year die of ovarian cancer, making it one of the deadliest gynecologic cancers.

Millions of women aged 15 to 20 years old in the United States may have received unnecessary Pap tests or bimanual pelvic exams in recent years, according to a study published in JAMA Internal Medicine.

WHO revised its recommendations on hormonal contraceptive use to say that women at high risk for HIV can use any form of reversible contraception — including implants, intrauterine devices and progestogen-only injectables — without an increased risk for infection.